UBS AM’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.77M | Sell |
396,167
-67,175
| -14% | -$1.15M | ﹤0.01% | 1551 |
|
|
2025
Q1 | $29.6M | Buy |
463,342
+164,041
| +55% | +$10.5M | 0.01% | 810 |
|
|
2024
Q4 | $36.4M | Buy |
299,301
+31,098
| +12% | +$3.78M | 0.01% | 740 |
|
|
2024
Q3 | $33.5M | Sell |
268,203
-33,278
| -11% | -$4.16M | 0.01% | 774 |
|
|
2024
Q2 | $47.6M | Buy |
301,481
+140,454
| +87% | +$22.2M | 0.01% | 625 |
|
|
2024
Q1 | $20.8M | Buy |
161,027
+15
| +0% | +$1.94K | 0.01% | 783 |
|
|
2023
Q4 | $15.5M | Sell |
161,012
-170
| -0.1% | -$16.4K | 0.01% | 840 |
|
|
2023
Q3 | $19.5M | Buy |
161,182
+4,493
| +3% | +$545K | 0.01% | 766 |
|
|
2023
Q2 | $21.6M | Hold |
156,689
| – | – | 0.01% | 747 |
|
|
2023
Q1 | $21.6M | Buy |
156,689
+35,368
| +29% | +$4.87M | 0.01% | 747 |
|
|
2022
Q4 | $15.7M | Buy |
121,321
+1,254
| +1% | +$162K | 0.01% | 810 |
|
|
2022
Q3 | $13.3M | Sell |
120,067
-18,440
| -13% | -$2.04M | 0.01% | 871 |
|
|
2022
Q2 | $10.4M | Buy |
138,507
+962
| +0.7% | +$72.1K | 0.01% | 944 |
|
|
2022
Q1 | $10.7M | Sell |
137,545
-27,201
| -17% | -$2.12M | ﹤0.01% | 1044 |
|
|
2021
Q4 | $14.8M | Buy |
164,746
+62,655
| +61% | +$5.64M | 0.01% | 985 |
|
|
2021
Q3 | $9.44M | Sell |
102,091
-9,632
| -9% | -$891K | ﹤0.01% | 1115 |
|
|
2021
Q2 | $8.69M | Sell |
111,723
-93,319
| -46% | -$7.25M | ﹤0.01% | 1170 |
|
|
2021
Q1 | $15.3M | Sell |
205,042
-201,513
| -50% | -$15M | 0.01% | 944 |
|
|
2020
Q4 | $69.3M | Buy |
406,555
+10,676
| +3% | +$1.82M | 0.03% | 496 |
|
|
2020
Q3 | $55.6M | Buy |
395,879
+340
| +0.1% | +$47.7K | 0.03% | 486 |
|
|
2020
Q2 | $63.4M | Sell |
395,539
-60,320
| -13% | -$9.67M | 0.04% | 429 |
|
|
2020
Q1 | $44.6M | Buy |
455,859
+4,386
| +1% | +$429K | 0.03% | 473 |
|
|
2019
Q4 | $58.3M | Buy |
451,473
+58,372
| +15% | +$7.53M | 0.04% | 486 |
|
|
2019
Q3 | $29.6M | Buy |
393,101
+96,536
| +33% | +$7.27M | 0.02% | 665 |
|
|
2019
Q2 | $45.1M | Buy |
296,565
+42,263
| +17% | +$6.42M | 0.03% | 560 |
|
|
2019
Q1 | $30.3M | Buy |
254,302
+9,919
| +4% | +$1.18M | 0.02% | 641 |
|
|
2018
Q4 | $26.7M | Buy |
244,383
+21,262
| +10% | +$2.32M | 0.02% | 635 |
|
|
2018
Q3 | $36M | Buy |
+223,121
| New | +$36M | 0.03% | 603 |
|